Short Interest in Elekta AB (publ) (OTCMKTS:EKTAY) Decreases By 98.9%

Elekta AB (publ) (OTCMKTS:EKTAY - Get Free Report) was the target of a significant decline in short interest in April. As of April 30th, there was short interest totalling 100 shares, a decline of 98.9% from the April 15th total of 9,400 shares. Based on an average daily trading volume, of 38,600 shares, the days-to-cover ratio is currently 0.0 days.

Elekta AB (publ) Price Performance

Shares of Elekta AB (publ) stock traded up $0.21 on Friday, reaching $7.37. 7,412 shares of the company were exchanged, compared to its average volume of 8,752. Elekta AB has a 1-year low of $6.52 and a 1-year high of $8.62. The company has a market cap of $2.82 billion, a P/E ratio of 19.88 and a beta of 1.16. The stock's 50 day moving average price is $7.33 and its 200-day moving average price is $7.51.

Elekta AB (publ) (OTCMKTS:EKTAY - Get Free Report) last announced its quarterly earnings results on Thursday, February 29th. The company reported $0.08 earnings per share (EPS) for the quarter. The firm had revenue of $426.51 million during the quarter. Elekta AB (publ) had a return on equity of 15.16% and a net margin of 7.88%. On average, research analysts predict that Elekta AB will post 0.41 earnings per share for the current fiscal year.

About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.